The results demonstrated that DKK2 is a prognostic marker representing shorter survival time despite the TNM stage, lymph node metastasis, and vascular invasion status (Figures 2(a)–2(f)). This evidence concerns the gene DKK2 and metastatic malignant neoplasm in the lymph nodes.